George Sands/LinkedIn, Pierre Elias/columbia.edu
Mar 8, 2026, 15:41
George Sands: AI Screening Tool for Early Detection of Heart Disease
George Sands, Former Senior Director at Pfizer, shared a post on LinkedIn:
“This is a phenomenal development, led by cardiologist Pierre Elias, at Columbia, where an ortho patient, without know cardio symptoms, was found to have a cardiology condition that was treated within the 7 days of diagnosis by this AI screening tool.
The future is here!
It will help patients and the clinicians who care for them. Bravo and thanks to Dr. Elias’s team.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke